<codeBook xmlns="ddi:codebook:2_5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:codebook:2_5 https://ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd" version="2.5"><docDscr><citation><titlStmt><titl>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</titl><IDNo agency="DOI">doi:10.7939/DVN/10902</IDNo></titlStmt><distStmt><distrbtr source="archive">UAL Dataverse</distrbtr><distDate>2016-10-21</distDate></distStmt><verStmt source="DVN"><version date="2017-05-26" type="RELEASED">2</version></verStmt><biblCit>Huang, Vivian; Elahi, Shokrollah; Madsen, Karen; Fedorak, Richard; Dieleman, Levinus; Wine, Eytan; Lumb, Rowan, 2016, "Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD", https://doi.org/10.7939/DVN/10902, UAL Dataverse, V2</biblCit></citation></docDscr><stdyDscr><citation><titlStmt><titl>Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy Predicts Preterm Delivery in Women with IBD</titl><IDNo agency="DOI">doi:10.7939/DVN/10902</IDNo></titlStmt><rspStmt><AuthEnty affiliation="University of Alberta">Huang, Vivian</AuthEnty><AuthEnty affiliation="University of Alberta">Elahi, Shokrollah</AuthEnty><AuthEnty affiliation="University of Alberta">Madsen, Karen</AuthEnty><AuthEnty affiliation="University of Alberta">Fedorak, Richard</AuthEnty><AuthEnty affiliation="University of Alberta">Dieleman, Levinus</AuthEnty><AuthEnty affiliation="University of Alberta">Wine, Eytan</AuthEnty><AuthEnty affiliation="University of Alberta">Lumb, Rowan</AuthEnty></rspStmt><prodStmt><producer affiliation="University of Alberta" URI="http://pregnancy.ibdclinic.ca/">Preconception and Pregnancy in Inflammatory Bowel Disease Clinical Research Program</producer><prodDate>2015</prodDate><prodPlac>Edmonton, Alberta</prodPlac><software>Microsoft Excel</software><software version="23">SPSS</software></prodStmt><distStmt><distrbtr source="archive">UAL Dataverse</distrbtr><contact affiliation="University of Alberta" email="pregibd@ualberta.ca">Huang, Vivian</contact><depDate>2016-09-29</depDate></distStmt></citation><stdyInfo><subject><keyword>Medicine, Health and Life Sciences</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">Crohn's disease</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">pregnancy</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">ulcerative colitis</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">cohort studies</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">infant</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">biomarkers</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">C-reactive protein</keyword><keyword vocab="MeSH" vocabURI="https://www.nlm.nih.gov/mesh/">inflammatory bowel diseases</keyword><keyword>faecal calprotectin</keyword></subject><abstract>The objective of this study was to evaluate whether a FCP measurement in the 2nd or 3rd trimester of pregnancy in women with IBD can predict preterm delivery.</abstract><sumDscr><timePrd cycle="P1" event="start" date="2014">2014</timePrd><timePrd cycle="P1" event="end" date="2017">2017</timePrd><collDate cycle="P1" event="start" date="2014">2014</collDate><collDate cycle="P1" event="end" date="2017">2017</collDate><dataKind>Clinical data; Biosamples</dataKind><nation>Canada</nation><geogCover>Edmonton</geogCover><geogCover>Alberta</geogCover><anlyUnit>Individuals</anlyUnit><universe>Adult women with IBD enrolled in the Preconception and Pregnancy in IBD clinic and healthy volunteers.</universe></sumDscr></stdyInfo><method><dataColl><frequenc>Data was collected at each clinical visit.</frequenc><sampProc>25 study participants were recruited through convenience sample.</sampProc><targetSampleSize><sampleSize>25</sampleSize></targetSampleSize><sources><srcChar>Clinical disease activity scores (modified Harvey Bradshaw Index (mHBI) for Crohn's disease and partial Mayo (pMayo) for ulcerative colitis) were obtained at each study visit. C-reactive protein and Fecal calprotectin were analysed: patients collected a first morning stool sample, which was analyzed for FCP using the Quantum Blue high range reader. Delivery outcomes (preterm (less than 37 weeks) and full term (37 or more weeks) and delivery method) were also obtained after birth.</srcChar></sources><collMode>Self-administered questionnaire: Paper; Physical measurements and tests</collMode><cleanOps>Data verification built into protocols.</cleanOps></dataColl><anlyInfo/></method><dataAccs><setAvail/><useStmt><conditions>Access to deidentified data may be permitted for external researchers, with limitations. Only researchers with REB-approved projects may be permitted access to the deidentified data. A basic data sharing agreement form is required (ie. Agree to not attempt to re-identify the records so as to relate the information on the file to a particular person). The data producer determines access on a case-by-case basis. Contact the data producer directly to discuss terms and conditions of access.</conditions></useStmt></dataAccs><othrStdyMat><relStdy>Effects of Maternal IBD and IBD Breast Milk on Neonatal Gut Microbiome and Intestinal Inflammation</relStdy><relStdy>Immunological Profiling</relStdy></othrStdyMat></stdyDscr><otherMat ID="f6854" URI="https://dataverse.library.ualberta.ca/api/access/datafile/6854" level="datafile"><labl>Huang FCP Presentation Feb 20, 2016.pdf</labl><txt>"Elevated Fecal Calprotectin in the Second or Third Trimester of Pregnancy predicts Preterm Delivery in Women with IBD" poster presentation. The presentation contains aggregate data tables.</txt><notes level="file" type="DATAVERSE:CONTENTTYPE" subject="Content/MIME Type">application/pdf</notes></otherMat></codeBook>